Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D/A Sep 23, 2021 SC 13D/A
8-K Sep 23, 2021 8-K
4 Sep 23, 2021 FORM 4 SUBMISSION
424B5 Sep 22, 2021 424B5
424B5 Sep 20, 2021 424B5
SC 13G Sep 10, 2021
3 Aug 26, 2021 FORM 3 SUBMISSION
SC 13G Aug 26, 2021 SCHEDULE 13G
10-Q Aug 12, 2021 10-Q
8-K Aug 11, 2021 8-K
4 Jul 27, 2021 FORM 4 SUBMISSION
3 Jul 27, 2021 FORM 3 SUBMISSION
3 Jul 27, 2021 PRIMARY DOCUMENT
8-K Jul 26, 2021 8-K
4 Jul 15, 2021 FORM 4 SUBMISSION
3 Jul 15, 2021 FORM 3 SUBMISSION
8-K Jul 15, 2021 8-K
4 Jun 16, 2021 FORM 4 SUBMISSION
4 Jun 16, 2021 FORM 4 SUBMISSION
4 Jun 16, 2021 FORM 4 SUBMISSION
8-K/A Jun 15, 2021 8-K/A
DEFA14A Jun 4, 2021 DEFA14A
8-K Jun 4, 2021 8-K
SC 13G/A Jun 1, 2021 SC 13G/A
8-K May 17, 2021 8-K
← Newer Page 14 of 33 · 817 filings Older →